Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015;25(4):261-74.
doi: 10.2188/jea.JE20140120. Epub 2015 Mar 14.

Effect of individual omega-3 fatty acids on the risk of prostate cancer: a systematic review and dose-response meta-analysis of prospective cohort studies

Yuan-Qing Fu  1 , Ju-Sheng Zheng, Bo Yang, Duo Li
Affiliations
Review

Effect of individual omega-3 fatty acids on the risk of prostate cancer: a systematic review and dose-response meta-analysis of prospective cohort studies

Yuan-Qing Fu et al. J Epidemiol. 2015.

Abstract

Epidemiological studies have suggested inconsistent associations between omega-3 polyunsaturated fatty acids (n-3 PUFAs) and prostate cancer (PCa) risk. We performed a dose-response meta-analysis of prospective observational studies investigating both dietary intake and circulating n-3 PUFAs and PCa risk. PubMed and EMBASE prior to February 2014 were searched, and 16 publications were eligible. Blood concentration of docosahexaenoic acid, but not alpha-linolenic acid or eicosapentaenoic acid, showed marginal positive association with PCa risk (relative risk for 1% increase in blood docosahexaenoic acid concentration: 1.02; 95% confidence interval, 1.00-1.05; I(2) = 26%; P = 0.05 for linear trend), while dietary docosahexaenoic acid intake showed a non-linear positive association with PCa risk (P < 0.01). Dietary alpha-linolenic acid was inversely associated with PCa risk (relative risk for 0.5 g/day increase in alpha-linolenic acid intake: 0.99; 95% confidence interval, 0.98-1.00; I(2) = 0%; P = 0.04 for linear trend), which was dominated by a single study. Subgroup analyses indicated that blood eicosapentaenoic acid concentration and blood docosahexaenoic acid concentration were positively associated with aggressive PCa risk and nonaggressive PCa risk, respectively. Among studies with nested case-control study designs, a 0.2% increase in blood docosapentaenoic acid concentration was associated with a 3% reduced risk of PCa (relative risk 0.97; 95% confidence interval, 0.94-1.00; I(2) = 44%; P = 0.05 for linear trend). In conclusion, different individual n-3 PUFA exposures may exhibit different or even opposite associations with PCa risk, and more prospective studies, especially those examining dietary n-3 PUFAs and PCa risk stratified by severity of cancer, are needed to confirm the results.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Flow diagram for selection of studies in the meta-analysis.
Figure 2.
Figure 2.. Dose-response relationship between dietary ALA intake and PCa risk. The dotted line represents the 95% confidence limits for the fitted curve.
Figure 3.
Figure 3.. Meta-analysis of PCa risk per 0.5 g/day increment of dietary ALA and per 0.05 g/day increment of dietary EPA. A random-effects model was used to estimate overall relative risk. Grey squares stand for study-specific relative risks, with the square size reflecting the corresponding weight and horizontal bars reflecting 95% confidence intervals.
Figure 4.
Figure 4.. Dose-response relationship between blood ALA concentration and PCa risk. The dotted line represents the 95% confidence limits for the fitted curve.
Figure 5.
Figure 5.. Meta-analysis of PCa risk per 0.1% increase in blood ALA concentration and per 0.2% increase in blood DPA concentration. A random-effects model was used to estimate overall relative risk. Grey squares stand for study-specific relative risks, with the square size reflecting the corresponding weight and horizontal bars reflecting 95% confidence intervals.
Figure 6.
Figure 6.. Dose-response relationship for dietary DHA and EPA intakes with PCa risk. The dotted line represents the 95% confidence limits for the fitted curve.
Figure 7.
Figure 7.. Dose-response relationship for blood concentration of DHA and EPA with PCa risk. The dotted line represents the 95% confidence limits for the fitted curve.
Figure 8.
Figure 8.. Meta-analysis of PCa risk per 1% increase in blood DHA concentration and per 0.5% increase in blood EPA concentration. A random-effects model was used to estimate overall relative risk. Grey squares stand for study-specific relative risks, with the square size reflecting the corresponding weight and horizontal bars reflecting 95% confidence intervals.
Figure 9.
Figure 9.. Dose-response relationship for blood DPA concentration with total PCa risk. The dotted line represents the 95% confidence limits for the fitted curve.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. 10.3322/caac.20107 - DOI - PubMed
    1. Lands WE. Dietary fat and health: the evidence and the politics of prevention: careful use of dietary fats can improve life and prevent disease. Ann NY Acad Sci. 2005;1055:179–92. 10.1196/annals.1323.028 - DOI - PubMed
    1. Chan JM, Stampfer MJ, Ma J, Gann PH, Gaziano JM, Giovannucci EL. Dairy products, calcium, and prostate cancer risk in the Physicians’ Health Study. Am J Clin Nutr. 2001;74:549–54. - PubMed
    1. Burdge GC, Jones AE, Wootton SA. Eicosapentaenoic and docosapentaenoic acids are the principal products of a-linolenic acid metabolism in young men. Br J Nutr. 2002;88:355–63. 10.1079/BJN2002662 - DOI - PubMed
    1. Wang S, Wu J, Suburu J, Cai J, Axanova LS, Gu Z, et al. . Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer. Carcinogenesis. 2012;33:404–12. 10.1093/carcin/bgr290 - DOI - PMC - PubMed

Substances